NexImmune Inc. (NEXI) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

NexImmune Inc.

OTC: NEXI · Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 04, 2025, 11:37 AM

NexImmune Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-32.34M -62.51M -50.9M
Depreciation & Amortization
1.02M 994.79K 870.28K
Stock-Based Compensation
3.55M 5.87M 5.98M
Other Working Capital
-3.84M 2.54M 1.66M
Other Non-Cash Items
1.21M 520.69K 903.92K
Deferred Income Tax
n/a n/a -3.29M
Change in Working Capital
-4.88M 3.93M 654.57K
Operating Cash Flow
-31.43M -51.19M -45.79M
Capital Expenditures
-48.72K -1.26M -2.35M
Cash Acquisitions
n/a 80.8K -32.06M
Purchase of Investments
n/a -21.51M -90.46M
Sales Maturities Of Investments
n/a 73M 39M
Other Investing Acitivies
4.23K 81.93M 32.06M
Investing Cash Flow
-44.49K 50.32M -53.81M
Debt Repayment
n/a n/a 9.02M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a 33.26K 1.15M
Financial Cash Flow
n/a 5.18M 124.89M
Net Cash Flow
-31.47M 4.3M 25.3M
Free Cash Flow
-31.48M -52.45M -48.14M